Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$114.20

1.12 (0.99%)

13:00
02/15/18
02/15
13:00
02/15/18
13:00

AbbVie trading resumes

  • 16

    Feb

  • 08

    Mar

ABBV AbbVie
$114.20

1.12 (0.99%)

01/30/18
01/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AbbVie (ABBV) downgraded to Underperform from Market Perform by analyst Alex Arfaei, who said the risk/reward has "meaningfully changed" after the rise in the stock price, adding that the new focus on fundamentals beyond the benefits of tax reform suggests "significant price erosion in immunology driven by interchangeable biosimilar anti-TNFs, and lower effectiveness of the 'Rebate Trap' to block access to cheap biosimilars". 2. iRobot (IRBT) downgraded to Neutral from Buy at Sidoti by analyst Frank Camma, who cited valuation as shares approach his $98 price target. 3. Horizon Global (HZN) downgraded to Market Perform from Outperform at BMO Capital by analyst Gerrick Johnson, who said that while he still sees "strong demand in key end markets," operation execution, rising input costs, and high debt levels are concerning. The analyst added that the company may have "lost the faith of investors" after a 30% drop in the stock price following the guidance cut. 4. Yum! Brands (YUM) downgraded to Neutral from Buy at Nomura Instinet by analyst Mark Kalinowshi, who cited valuation and concerns a possible 2018 slowdown in U.S. same-store-sales. 5. Alaska Air (ALK) downgraded to Underweight from Neutral at JPMorgan by analyst Jamie Baker, who noted that the airline is the only name where he had to cut his 2019 estimates. He also believes the company "remains in the United crosshairs in San Francisco." The analyst also downgraded Southwest (LUV) to Neutral from Overweight, and said he believes better relative value exists elsewhere in the Airlines sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/18
JEFF
01/31/18
NO CHANGE
JEFF
Jefferies sees neutral impact on Biotech from State of the Union
Jefferies analyst Michael Yee sees a net neutral impact on Biotech stocks from President Trump's State of the Union speech last night. During the speech, Trump made comments about making lower drug prices a "priority" for the year, Yee tells investors in a research not titled "Drug Pricing Comments Not New or Surprising - But a Reminder of Rhetoric." The President, however, also commented on broader access to novel clinical trial drugs, Yee points out. After a "strong biotech rally" in January, the analyst assumes the sector, "at some point," will have some relative near-term pullback either on uncertainty about Trump commentary or some consolidation. Some of the analyst's Buy-rated names include AbbVie (ABBV), Amgen (AMGN), Eli Lilly (LLY) and Gilead Sciences (GILD).
02/02/18
ARGS
02/02/18
NO CHANGE
Target $145
ARGS
Buy
AbbVie price target raised to $145 from $120 at Argus
Argus analyst David Toung raised his price target on AbbVie to $145 and kept his Buy rating after a "solid" Q4 earnings report that also included a substantial boost from lower tax rates. Toung says AbbVie is likely to submit more applications for new products and expanded indications of existing drugs this year as it develops new growth drivers such as Imbruvica and Mavyret to complement the current large contribution from Humira.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $25
JEFF
Hold
Acorda remains takeover candidate after competitor data, says Jefferies
Jefferies analyst Michael Yee believes the positive Phase III topline results from Acorda Therapeutics (ACOR) competitor Sunovion for APL-130277 in Parkinson's patients came in as expected. While APL-130277 data compares favorably over Inbrija's 3.92 point difference at week 12, Yee cautions to compare directly head-to-head since patient baseline characteristics could be different. Acorda remains a "reasonably likely" acquisition candidate in 2018 given its $300M-$500M-plus Parkinson's asset Inbrija, Yee tells investors in a research note. The analyst does not think Biogen (BIIB) should buy the company, but sees other potential suitors in AbbVie (ABBV), Allergan (AGN), Mitsubishi, Roche (RHHBY) and Shire (SHPG). He believes a takeover price could be north of $2B. Yee keeps a Hold rating on Acorda with a $25 price target.

TODAY'S FREE FLY STORIES

CBS

CBS

$46.15

-0.66 (-1.41%)

, ORCL

Oracle

$46.19

0.47 (1.03%)

13:01
12/18/18
12/18
13:01
12/18/18
13:01
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks started strong and…

CBS

CBS

$46.15

-0.66 (-1.41%)

ORCL

Oracle

$46.19

0.47 (1.03%)

JNJ

Johnson & Johnson

$131.92

2.81 (2.18%)

BA

Boeing

$330.55

14.17 (4.48%)

TLRY

Tilray

$73.29

7.4 (11.23%)

NVS

Novartis

$85.67

-0.13 (-0.15%)

NAV

Navistar

$26.72

2.88 (12.08%)

RCII

Rent-A-Center

$12.45

-2 (-13.84%)

LXFR

Luxfer

$17.87

-3.55 (-16.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 05

    Jan

  • 27

    Jan

ALB

Albemarle

$81.65

1.15 (1.43%)

12:57
12/18/18
12/18
12:57
12/18/18
12:57
Periodicals
Breaking Periodicals news story on Albemarle »

Albemarle named a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:56
12/18/18
12/18
12:56
12/18/18
12:56
Hot Stocks
DOJ says Germany's IAV GmbH to pay $35M fine for role in VW emissions fraud »

IAV GmbH, IAV, a German…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$12.41

-2.04 (-14.12%)

12:52
12/18/18
12/18
12:52
12/18/18
12:52
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

MEET

Meet Group

$3.89

0.51 (15.09%)

12:50
12/18/18
12/18
12:50
12/18/18
12:50
Hot Stocks
Meet Group jumps almost 16% after rollout of Battles »

Shares of mobile social…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$88.17

0.09 (0.10%)

12:46
12/18/18
12/18
12:46
12/18/18
12:46
Hot Stocks
Duke Energy provides update on progress to close coal ash basins »

Duke Energy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.57

0.08 (2.29%)

12:45
12/18/18
12/18
12:45
12/18/18
12:45
Recommendations
Apollo Endosurgery analyst commentary  »

Apollo Endosurgery target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$104.20

-1.13 (-1.07%)

12:44
12/18/18
12/18
12:44
12/18/18
12:44
Recommendations
Grand Canyon analyst commentary  »

Barrington views Grand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$104.20

-1.13 (-1.07%)

12:43
12/18/18
12/18
12:43
12/18/18
12:43
Hot Stocks
Grand Canyon to acquire Orbis Education Services »

Before the market open,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$53.15

1.46 (2.82%)

12:40
12/18/18
12/18
12:40
12/18/18
12:40
Options
Put spreads in Dow DuPont as shares gain 3% »

Put spreads in Dow DuPont…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$12.33

0.05 (0.41%)

12:32
12/18/18
12/18
12:32
12/18/18
12:32
Hot Stocks
Maxar's SSL awarded contract to provide GEO satellite for Ovzon »

SSL, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAYX

Paychex

$64.72

-0.23 (-0.35%)

, GIS

General Mills

$37.18

0.45 (1.23%)

12:30
12/18/18
12/18
12:30
12/18/18
12:30
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$64.72

-0.23 (-0.35%)

GIS

General Mills

$37.18

0.45 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

FDX

FedEx

$185.39

3.19 (1.75%)

, MU

Micron

$34.59

0.7 (2.07%)

12:30
12/18/18
12/18
12:30
12/18/18
12:30
Earnings
Notable companies reporting after market close »

Notable companies…

FDX

FedEx

$185.39

3.19 (1.75%)

MU

Micron

$34.59

0.7 (2.07%)

JBL

Jabil

$22.09

0.53 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 08

    Jan

ALV

Autoliv

$73.57

1.8 (2.51%)

12:29
12/18/18
12/18
12:29
12/18/18
12:29
Downgrade
Autoliv rating change  »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

XRX

Xerox

$21.25

-0.02 (-0.09%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Options
Xerox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

BPMUF

Basilea Pharmaceutica

$0.00

(0.00%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Federal Reserve Board to hold a closed meeting »

The Federal Reserve holds…

GM

General Motors

$35.20

0.54 (1.56%)

12:23
12/18/18
12/18
12:23
12/18/18
12:23
Periodicals
GM to cut 50 jobs at Detroit lithium-ion battery assembly plant, Reuters reports »

General Motors will cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$93.27

1.92 (2.10%)

12:21
12/18/18
12/18
12:21
12/18/18
12:21
Hot Stocks
PVH Corp. CEO Chirico acquires 10,000 shares for $95.51 »

PVH Corp. CEO Emanuel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/18/18
12/18
12:17
12/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/18/18
12/18
12:16
12/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOXO

XO Group

$35.00

0.015 (0.04%)

12:12
12/18/18
12/18
12:12
12/18/18
12:12
Hot Stocks
XO Group shareholders approve merger with WeddingWire »

XO Group announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$24.00

0.78 (3.36%)

12:05
12/18/18
12/18
12:05
12/18/18
12:05
Options
DSW call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$19.06

-2.36 (-11.02%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Luxfer falls -10.9% »

Luxfer is down -10.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BPT

BP Prudhoe Bay

$22.75

-2.745 (-10.77%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
BP Prudhoe Bay falls -11.2% »

BP Prudhoe Bay is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.